MCID: CLT003
MIFTS: 58

Colitis

Categories: Gastrointestinal diseases

Aliases & Classifications for Colitis

MalaCards integrated aliases for Colitis:

Name: Colitis 12 29 52 42 14 69

Classifications:



External Ids:

Disease Ontology 12 DOID:0060180
ICD10 33 K52.9
MeSH 42 D003092
NCIt 47 C26723
SNOMED-CT 64 64226004
UMLS 69 C0009319

Summaries for Colitis

Disease Ontology : 12 An inflammatory bowel disease that involves inflammation located in colon.

MalaCards based summary : Colitis is related to lymphocytic colitis and crohn's colitis. An important gene associated with Colitis is NOD2 (Nucleotide Binding Oligomerization Domain Containing 2), and among its related pathways/superpathways are Innate Immune System and ERK Signaling. The drugs Infliximab and Sucralfate have been mentioned in the context of this disorder. Affiliated tissues include colon, t cells and neutrophil, and related phenotypes are Synthetic lethal with MLN4924 (a NAE inhibitor) and hematopoietic system

Wikipedia : 72 Colitis is an inflammation of the colon. Colitis may be acute and self-limited or long-term. It broadly... more...

Related Diseases for Colitis

Diseases related to Colitis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 707)
id Related Disease Score Top Affiliating Genes
1 lymphocytic colitis 34.7 IFNG IL2 TNF
2 crohn's colitis 34.5 MYO9B NOD2 TNF
3 pericholangitis 31.3 MPO MUC2 TNF
4 gastroduodenal crohn's disease 30.7 IL17A MPO NOD2 TNF
5 primary biliary cirrhosis 30.3 IL10 IL10RA TNF
6 colorectal cancer 30.3 ABCB1 AKT1 CTNNB1 IFNG IL10 IL1B
7 myelitis 30.3 IFNG IL10 IL2
8 autoimmune polyglandular syndrome type 3 30.3 IFNG IL2 TNF
9 pyelonephritis 30.2 IL10 IL1B TNF
10 microscopic colitis 30.0 ABCB1 AKT1 ATG16L1 CTNNB1 IFNG IL10
11 cryptococcosis 30.0 IL10 IL17A TNF
12 colon adenocarcinoma 30.0 IL10 IL1B TNF
13 rheumatoid arthritis 30.0 IFNG IL10 IL17A IL1B IL2 TNF
14 epidermolysis bullosa acquisita 30.0 IFNG IL10 IL17A
15 membranoproliferative glomerulonephritis 29.6 IFNG IL2 NOD2 TLR9 TNF
16 lymphoma 29.4 IFNG IL10 IL17A IL1B IL2 TLR9
17 pulmonary embolism 29.4 IFNG IL10 IL1B TLR9 TNF
18 inner ear disease 29.3 IFNG IL10 TLR9 TNF
19 gastric ulcer 29.2 IFNG IL10 IL2 TLR9 TNF
20 legionellosis 29.2 IFNG IL1B IL2 TLR9 TNF
21 systemic lupus erythematosus 29.0 IFNG IL10 IL17A IL2 MPO TLR9
22 hepatic angiomyolipoma 28.9 IFNG IL17A IL1B TLR9
23 ulcerative colitis 12.5
24 collagenous colitis 12.3
25 chemical colitis 12.3
26 diversion colitis 12.2
27 ischemic colitis 12.2
28 clostridium difficile colitis 12.1
29 cutaneous photosensitivity and colitis, lethal 12.0
30 eosinophilic colitis 12.0
31 pediatric ulcerative colitis 11.9
32 undetermined colitis 11.8
33 obesity-colitis-hypothyroidism-cardiac hypertrophy-developmental delay syndrome 11.7
34 epithelio-exfoliative colitis-deafness syndrome 11.7
35 leukoencephalopathy, arthritis, colitis, and hypogammaglobulinema 11.7
36 crohn's disease 11.6
37 crohn disease-associated growth failure 11.3
38 inflammatory bowel disease 11.3
39 gastroenteritis 11.3
40 ulcerative proctitis 11.2
41 amebiasis 11.2
42 pouchitis 11.2
43 irritable bowel syndrome 11.1
44 inflammatory bowel disease 25, early onset, autosomal recessive 11.1
45 autoimmune oophoritis 11.1 MPO TNF
46 scirrhous adenocarcinoma 11.1 IL2 TNF
47 pyoderma gangrenosum 11.0
48 pure autonomic failure 11.0 IL10 TNF
49 idiopathic dilatation of the pulmonary artery 11.0 IL10 IL23R TNF
50 microcephaly, short stature, and limb abnormalities 11.0 IL10 IL10RA IL10RB

Graphical network of the top 20 diseases related to Colitis:



Diseases related to Colitis

Symptoms & Phenotypes for Colitis

GenomeRNAi Phenotypes related to Colitis according to GeneCards Suite gene sharing:

26
id Description GenomeRNAi Source Accession Score Top Affiliating Genes
1 Synthetic lethal with MLN4924 (a NAE inhibitor) GR00250-A-1 9.88 TNF AKT1 IL10 IL17A IL1B IL2
2 Synthetic lethal with MLN4924 (a NAE inhibitor) GR00250-A-2 9.88 AKT1 IL10 IL17A IL1B IL2 MPO

MGI Mouse Phenotypes related to Colitis:

44 (show all 15)
id Description MGI Source Accession Score Top Affiliating Genes
1 hematopoietic system MP:0005397 10.45 IL10RA IL10RB IL17A IL1B IL2 IL23R
2 homeostasis/metabolism MP:0005376 10.41 ABCB1 AKT1 ATG16L1 CTNNB1 IFNG IL10
3 immune system MP:0005387 10.41 SMAD4 TLR9 TNF ABCB1 AKT1 ATG16L1
4 digestive/alimentary MP:0005381 10.4 ABCB1 ATG16L1 CTNNB1 IFNG IL10 IL10RA
5 cellular MP:0005384 10.38 CTNNB1 IFNG IL10 IL10RA IL10RB IL2
6 growth/size/body region MP:0005378 10.34 ABCB1 AKT1 ATG16L1 CTNNB1 IFNG IL10
7 cardiovascular system MP:0005385 10.33 IL1B IL2 MPO MUC2 SMAD4 TNF
8 endocrine/exocrine gland MP:0005379 10.32 ATG16L1 CTNNB1 IFNG IL10 IL10RB IL17A
9 mortality/aging MP:0010768 10.27 IL17A IL1B IL2 MPO MUC2 NOD2
10 liver/biliary system MP:0005370 10.06 TNF ABCB1 AKT1 CTNNB1 IFNG IL10
11 neoplasm MP:0002006 9.96 AKT1 CTNNB1 IFNG IL10 IL1B IL2
12 muscle MP:0005369 9.92 AKT1 ATG16L1 CTNNB1 IFNG IL10 MPO
13 no phenotypic analysis MP:0003012 9.76 ABCB1 CTNNB1 IFNG IL10 IL17A IL2
14 respiratory system MP:0005388 9.56 CTNNB1 IFNG IL10 IL10RB IL17A IL2
15 skeleton MP:0005390 9.28 AKT1 CTNNB1 IFNG IL10 IL17A IL1B

Drugs & Therapeutics for Colitis

Drugs for Colitis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 383)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Infliximab Approved Phase 4,Phase 2,Phase 3,Phase 1 170277-31-3
2
Sucralfate Approved Phase 4 54182-58-0
3
Adalimumab Approved Phase 4,Phase 3,Phase 2,Phase 1 331731-18-1 16219006
4
Ciprofloxacin Approved, Investigational Phase 4,Phase 3,Phase 2 85721-33-1 2764
5
Iron Approved Phase 4,Phase 3,Phase 2 7439-89-6 23925
6
Azathioprine Approved Phase 4,Phase 2,Phase 3 446-86-6 2265
7
Prednisone Approved, Vet_approved Phase 4,Phase 2,Phase 3 53-03-2 5865
8
Doxycycline Approved, Investigational, Vet_approved Phase 4,Phase 2 564-25-0 54671203
9
Aminosalicylic Acid Approved Phase 4,Phase 3,Phase 2,Phase 1 65-49-6 4649
10
Vancomycin Approved Phase 4,Phase 3,Phase 2,Phase 1 1404-90-6 441141 14969
11
Loperamide Approved Phase 4,Phase 3,Phase 2 53179-11-6 3955
12
Miconazole Approved, Investigational, Vet_approved Phase 4,Phase 2 22916-47-8 4189
13
Benzocaine Approved Phase 4,Phase 3,Phase 1 1994-09-7, 94-09-7 2337
14
Tacrolimus Approved, Investigational Phase 4,Phase 3,Phase 2 104987-11-3 445643 439492
15
Menthol Approved Phase 4,Phase 2 2216-51-5 16666
16
Rifaximin Approved, Investigational Phase 4 80621-81-4 6436173
17
Bupropion Approved Phase 4 34841-39-9, 34911-55-2 444
18
Dopamine Approved Phase 4 51-61-6, 62-31-7 681
19
Cefazolin Approved Phase 4,Phase 2,Phase 3 25953-19-9 656510 33255
20
Clindamycin Approved, Vet_approved Phase 4 18323-44-9 29029
21
Amoxicillin Approved, Vet_approved Phase 4,Phase 3 26787-78-0 33613 2171
22
Metronidazole Approved Phase 4,Phase 3,Phase 2,Phase 1 443-48-1 4173
23
Nicotine Approved Phase 4 54-11-5 942 89594
24 Vedolizumab Approved Phase 4,Phase 3,Phase 2,Early Phase 1 943609-66-3
25
Hydrocortisone Approved, Vet_approved Phase 4,Phase 1,Phase 2 50-23-7 5754 657311
26
Methylprednisolone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 83-43-2 6741
27
Prednisolone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 50-24-8 5755
28
Guaifenesin Approved, Vet_approved Phase 4,Phase 3,Phase 1 93-14-1 3516
29
Omeprazole Approved, Investigational, Vet_approved Phase 4,Phase 1,Phase 2 73590-58-6 4594
30
Sulfamethoxazole Approved Phase 4 723-46-6 5329
31
Trimethoprim Approved, Vet_approved Phase 4 738-70-5 5578
32
Methotrexate Approved Phase 4,Phase 2 1959-05-2, 59-05-2 126941
33
Dextromethorphan Approved Phase 4 125-71-3 5360696 5362449
34
Losartan Approved Phase 4 114798-26-4 3961
35
Midazolam Approved, Illicit Phase 4 59467-70-8 4192
36
Ursodeoxycholic acid Approved, Investigational Phase 4 128-13-2 31401
37
Copper Approved Phase 4 7440-50-8 27099
38
Zinc Approved Phase 4 7440-66-6 32051 23994
39
Thioguanine Approved Phase 4 154-42-7 2723601
40
Cephalexin Approved, Vet_approved Phase 4 15686-71-2 27447
41
Nitrofurantoin Approved, Vet_approved Phase 4 67-20-9 5353830
42
Gabapentin Approved, Investigational Phase 4 60142-96-3 3446
43 tannic acid Approved, Nutraceutical Phase 4,Phase 3,Phase 1
44
Folic Acid Approved, Nutraceutical, Vet_approved Phase 4,Phase 2,Phase 1 59-30-3 6037
45
leucovorin Approved, Nutraceutical Phase 4,Phase 2 58-05-9 143 6006
46
Vitamin C Approved, Nutraceutical Phase 4 50-81-7 5785 54670067
47
Cholecalciferol Approved, Nutraceutical Phase 4,Phase 3,Phase 1,Phase 2 67-97-0 6221 10883523 5280795
48
Ergocalciferol Approved, Nutraceutical Phase 4,Phase 3,Phase 1,Phase 2 50-14-6 5280793
49
Vitamin D Approved, Nutraceutical, Vet_approved Phase 4,Phase 3,Phase 1,Phase 2 1406-16-2
50
Caffeine Approved, Nutraceutical Phase 4 58-08-2 2519

Interventional clinical trials:

(show top 50) (show all 1039)

id Name Status NCT ID Phase Drugs
1 Role of Healthy Bacteria in Ulcerative Colitis Unknown status NCT01479660 Phase 4 Probiotic
2 Golimumab in Steroid-dependent Ulcerative Colitis: Induction and Maintenance of Clinical and Endoscopic Remission Unknown status NCT02412085 Phase 4 Golimumab
3 Physiological Intermolecular Modification Spectroscopy (PIMS) in Ulcerative Colitis With Golimumab Unknown status NCT02186886 Phase 4 Golimumab
4 Clostridial Infection and Oral Lavage -Improving Treatment Before Illness Becomes Severe Unknown status NCT01630096 Phase 4 Nu-Lytely
5 "Efficacy and Safety of Infliximab-biosimilar (Inflectra) Compared to Infliximab-innovator (Remicade) in Patients With Inflammatory Bowel Disease in Remission: the SIMILAR Trial" Unknown status NCT02452151 Phase 4 Infliximab-Biosimilar;Infliximab-Innovator
6 The Effect of Probiotics on the Rate of Recovery of Inflammatory Bowel Disease Exacerbation, Endothelial Function, and Markers of Inflammation Unknown status NCT01078935 Phase 4
7 Confocal Endomicroscopy During Endoscopy Unknown status NCT00988273 Phase 4
8 A Prospective, Placebo Controlled, Double-Blind, Cross-over Study on the Effects of a Probiotic Preparation (VSL#3) on Metabolic Profile, Intestinal Permeability, Microbiota, Cytokines and Chemokines Expression and Other Inflammatory Markers in Pediatric Unknown status NCT01632462 Phase 4 VSL#3
9 The Effect of Probiotics on Exacerbation of Inflammatory Bowel Disease Exacerbation (Crohn's Disease) Unknown status NCT01765998 Phase 4 Probiotic;Placebo
10 Manipulation of Visceral Sensitivity and Immune System in IBS Unknown status NCT00418340 Phase 4 probiotic (bacterial/dietary supplement)
11 ZeroTolerance Mucositis: Managing Oral and Alimentary Mucositis With High Potency Sucralfate - ProThelial Unknown status NCT02016807 Phase 4
12 Pain Relief In Irritable Bowel Syndrome Unknown status NCT02573844 Phase 4 Proklama
13 Use of Combined Measurements of Serum Infliximab and Anti-infliximab Antibodies in the Treatment of Patients With Crohns Disease Failing Infliximab Therapy Unknown status NCT00851565 Phase 4
14 Golimumab Utilization and Impact on Ulcerative Colitis (MK-8259-032) Completed NCT02092285 Phase 4 Golimumab
15 Treatment of Ulcerative Colitis With Ciprofloxacin and E. Coli Nissle Completed NCT01772615 Phase 4 Ciprofloxacin
16 A Long Term Safety Study of Infliximab (Remicade) in in Ulcerative Colitis Patients Completed NCT00207688 Phase 4 Infliximab 5 mg/kg;Infliximab 10 mg/kg;Placebo
17 Evaluation of Histologic and Endoscopic Remission Induced by Infliximab in Moderate to Severe Ulcerative Colitis Completed NCT01408810 Phase 4 Infliximab
18 Strategies in Maintenance for Patients Receiving Long-term Therapy (S.I.M.P.L.E.) With MMX (Multi-Matrix System) Mesalamine for Ulcerative Colitis (UC) Completed NCT00446849 Phase 4 MMX Mesalamine
19 Study Comparing Cyclosporine With Infliximab in Steroid-refractory Severe Attacks of Ulcerative Colitis Completed NCT00542152 Phase 4 CYCLOSPORINE VS INFLIXIMAB
20 European Safety Registry in Ulcerative Colitis (Study P04808AM3) Completed NCT00705484 Phase 4 Standard Therapy
21 Once Versus Twice Daily Mesalamine to Induce Remission in Pediatric Ulcerative Colitis Completed NCT01201122 Phase 4 Mesalamine
22 Asacol Dosing Study for Active Ulcerative Colitis Completed NCT00194818 Phase 4 Asacol (mesalamine)
23 Preference for a Prefilled Syringe or Smartject™ Device for Delivering Golimumab in Participants Suffering From Moderate-to-severe Ulcerative Colitis (MK-8259-027) Completed NCT02155335 Phase 4 Prefilled Syringe delivery of Golimumab;Smartject Device delivery of Golimumab
24 Adacolumn in Refractory UC Patients Trial Completed NCT01481142 Phase 4
25 Dose Escalation and Remission (DEAR) Completed NCT00652145 Phase 4 mesalamine
26 Ability to Maintain or Achieve Clinical and Endoscopic Remission With MMX Mesalamine Once Daily in Adults With Ulcerative Colitis Completed NCT01124149 Phase 4 MMX mesalamine/ mesalazine
27 Correlation of Soluble ST2 With Golimumab (MK-8259) Response in Participants With Ulcerative Colitis (UC) (MK-8529-022). Completed NCT02318667 Phase 4
28 Study for the Treatment of Ulcerative Colitis With Adacolumn (Companion to US Study 512-04-205) Completed NCT00219414 Phase 4
29 Association Between Response to Treatment of C. Diff Colitis and Anti-C.Diff Toxin Antibody Completed NCT00304408 Phase 4
30 Rectal Tacrolimus in the Treatment of Resistant Ulcerative Proctitis Completed NCT01418131 Phase 4 Rectal tacrolimus;Placebo
31 The NOR-SWITCH Study Completed NCT02148640 Phase 4 Innovator infliximab;Biosimilar infliximab
32 Safety of Accelerated Infliximab Infusions in Patients With Inflammatory Bowel Disease (IBD) Completed NCT01346826 Phase 4 Standard 2 hours-infusion;Accelerated 1 hour-infusion;Accelerated 30 minutes-infusion
33 Treatment of Iron Deficiency Anaemia in Inflammatory Bowel Disease With Ferrous Sulphate Completed NCT01991314 Phase 4 Ferrous sulphate
34 Low Volume Colon Preparation for IBD Completed NCT02248337 Phase 4 Colon preparation for colonoscopy
35 Induction of Immunity Against Streptococcus Pneumoniae in Adults With Inflammatory Bowel Disease Completed NCT01908283 Phase 4
36 Impact of Six Patient Information Leaflets (PIL) on Doctor Patient Communication Completed NCT02246361 Phase 4
37 Single-dose Linaclotide for Capsule Endoscopy Preparation Completed NCT02465385 Phase 4 Linaclotide
38 The Influence of 5–Aminosalicylates on Thiopurine Metabolite Levels Completed NCT00167882 Phase 4 5-aminosalicylate (Pentasa, Ferring)
39 Immunogenicity of Hepatitis A Vaccine in Inflammatory Bowel Disease (IBD) Patients Completed NCT01341808 Phase 4
40 Steroid-induced Mood Changes in Patients With Inflammatory Bowel Disease Completed NCT01981889 Phase 4 Prednisone
41 Rifaximin for Preventing Relapse of Clostridium Associated Diarrhoea Completed NCT01670149 Phase 4 Rifaximin;Placebo
42 Efficacy Study of Pneumococcal Vaccination in Crohn's Disease Completed NCT01505855 Phase 4 23-valent polysaccharide pneumococcal vaccine
43 Intestinal Inflammation in Ankylosing Spondylitis and the Effects of Adalimumab on Mucosal Healing Completed NCT01174186 Phase 4 Adalimumab
44 Immune Response to the Human Papillomavirus Vaccine in Young Women With Inflammatory Bowel Disease Completed NCT01034358 Phase 4
45 A Trial of Iron Replacement in Patients With Iron Deficiency. Completed NCT01067547 Phase 4 Iron Sucrose.;Iron sucrose
46 Treating Disrupted Sleep in Individuals With Inflammatory Bowel Disease Completed NCT02162862 Phase 4 bupropion-SR
47 Postoperative Antibiotic Requirements Following Immediate Breast Reconstruction Completed NCT01244698 Phase 4 Cefadroxil discontinued early;Cefadroxil until drain removal
48 Use of a Novel Diet (UC DIET) for Treatment of Mild to Moderate Active Pediatric Ulcerative Colitis Recruiting NCT02345733 Phase 4 Antibiotic cocktail
49 Optimising Infliximab Induction Therapy for Acute Severe Ulcerative Colitis Recruiting NCT02770040 Phase 4 Infliximab
50 Golimumab (GLM) Dose Optimisation to Adequate Levels to Achieve Response in Colitis Recruiting NCT02687724 Phase 4 Golimumab (GLM)

Search NIH Clinical Center for Colitis

Cochrane evidence based reviews: colitis

Genetic Tests for Colitis

Genetic tests related to Colitis:

id Genetic test Affiliating Genes
1 Colitis 29

Anatomical Context for Colitis

MalaCards organs/tissues related to Colitis:

39
Colon, T Cells, Neutrophil, Testes, Bone, Liver, Monocytes

Publications for Colitis

Articles related to Colitis:

(show top 50) (show all 4495)
id Title Authors Year
1
Effects of a New Hospital-Wide Surgical Consultation Protocol in Patients with Clostridium difficile Colitis. ( 28557651 )
2017
2
Early Transcriptomic Changes in the Ileal Pouch Provide Insight into the Molecular Pathogenesis of Pouchitis and Ulcerative Colitis. ( 28221248 )
2017
3
IL23R single nucleotide polymorphisms could be either beneficial or harmful in ulcerative colitis. ( 28210080 )
2017
4
Treatment of chronic granulomatous disease-associated fistulising colitis with vedolizumab. ( 28919373 )
2017
5
Total glucosides of paeony ameliorates TNBSa89induced colitis by modulating differentiation of Th17/Treg cells and the secretion of cytokines. ( 28944916 )
2017
6
Activation of NLRP3 Inflammasome in Inflammatory Bowel Disease: Differences Between Crohn's Disease and Ulcerative Colitis. ( 28523573 )
2017
7
Gastrointestinal diseases and their oro-dental manifestations: Part 2: Ulcerative colitis. ( 28084352 )
2017
8
Ischemic colitis of the colon in streptozotocin-induced diabetic rats. ( 28780750 )
2017
9
Completion Proctectomy for Crohn's Colitis: Lessons Learned. ( 28158506 )
2017
10
Fulminant gangrenous ischemic colitis: is it the solely severe type of ischemic colitis? ( 27838817 )
2017
11
Efficacy of granulocyte and monocyte apheresis for antibiotic-refractory pouchitis after proctocolectomy for ulcerative colitis: an open-label, prospective, multicentre study. ( 28203278 )
2017
12
The Ileitis of Ulcerative Colitis. Why Is It Not Crohn's Disease? ( 28079623 )
2017
13
A Case of Type II Enteropathy-Associated T-Cell Lymphoma in a Patient With Ulcerative Colitis. ( 28572650 )
2017
14
A case of collagenous colitis associated with novel oral anticoagulants use. ( 28260714 )
2017
15
Squamous cell dysplasia in the proximal rectum of three patients treated for ulcerative colitis on immunomodulators. ( 28091842 )
2017
16
Efficacy and safety of single fecal microbiota transplantation for Japanese patients with mild to moderately active ulcerative colitis. ( 27730312 )
2017
17
Oligoclonal T-cell Receptor Repertoire in Colonic Biopsies of Patients with Microscopic Colitis and Ulcerative Colitis. ( 28498152 )
2017
18
Integrated strategy of differentially expressed genes associated with ulcerative colitis. ( 28944823 )
2017
19
Endoscopic findings and colonic perforation in microscopic colitis: A systematic review. ( 28847471 )
2017
20
Current Approach to the Evaluation and Management of Microscopic Colitis. ( 28265892 )
2017
21
Prevalence, Pathogenesis, Diagnosis, and Management of Microscopic Colitis. ( 28669150 )
2017
22
Improving remission rates in newly diagnosed paediatric ulcerative colitis. ( 28939375 )
2017
23
Morphological Changes in the Thymus, Composition of Its Cells, and Subpopulations of Peripheral Blood Lymphocytes during Experimental Acute Ulcerative Colitis. ( 28944427 )
2017
24
Protective role of liriodendrin in mice with dextran sulphate sodium-induced ulcerative colitis. ( 28941417 )
2017
25
Oroxylin A inhibits colitis by inactivating NLRP3 inflammasome. ( 28938606 )
2017
26
Differential diagnosis in ulcerative colitis in an adolescent: Chronic granulomatous disease needs extra attention. ( 28573071 )
2017
27
Review article: dose optimisation of infliximab for acute severe ulcerative colitis. ( 28074618 )
2017
28
Th1 Pathway: The Missing Link Between Inflammatory Bowel Disease and Microscopic Colitis? ( 28776143 )
2017
29
Effect of threatening life experiences and adverse family relations in ulcerative colitis: analysis using structural equation modeling and comparison with Crohn's disease. ( 28059861 )
2017
30
Sijunzi Decoction attenuates 2, 4, 6-trinitrobenzene sulfonic acid (TNBS)-induced colitis in rats and ameliorates TNBS-induced claudin-2 damage via NF-I_B pathway in Caco2 cells. ( 28073341 )
2017
31
Chromofungin Ameliorates the Progression of Colitis by Regulating Alternatively Activated Macrophages. ( 28951733 )
2017
32
Pouchitis after ileal pouch-anal anastomosis in ulcerative colitis: Diagnosis, management, risk factors, and incidence. ( 27681447 )
2017
33
Correlation of endoscopic disease severity with pediatric ulcerative colitis activity index score in children and young adults with ulcerative colitis. ( 28566893 )
2017
34
The miR-200 family is increased in dysplastic lesions in ulcerative colitis patients. ( 28288169 )
2017
35
Intraepidermal neutrophilic dermatosis type of IgA pemphigus with circulating linear IgA disease antibodies associated with ulcerative colitis. ( 28653439 )
2017
36
Clostridium Difficile, Colitis, and Colonoscopy: Pediatric Perspective. ( 28707191 )
2017
37
Endoscopic features of microscopic colitis: The "grid-like" pattern detected with HD+ colonoscopy plus i-scan. ( 28174001 )
2017
38
Cytomegalovirus Gastric Ulcer Complicated with Pyloric Obstruction in a Patient with Ulcerative Colitis. ( 28637105 )
2017
39
Continuing Medical Education: January 2017: Diagnosis and Management of Microscopic Colitis. ( 28050030 )
2017
40
Non-granulomatous myositis in a patient with ulcerative colitis who showed symptoms resembling gastrocnemius myalgia syndrome. ( 28132973 )
2017
41
Letter: the definition of budesonide dependence in microscopic colitis-authors' reply. ( 28805323 )
2017
42
Colectomy in refractory Crohn's colitis improves nutrition and reduces steroid use. ( 28864042 )
2017
43
Extended-release Multimatrix Budesonide for Microscopic Colitis. ( 28328627 )
2017
44
Usefulness of fecal calprotectin for the early prediction of short-term outcomes of remission-induction treatments in ulcerative colitis in comparison with two-item patient-reported outcome. ( 28934315 )
2017
45
Manipulation of the Endocannabinoid System in Colitis: A Comprehensive Review. ( 28079617 )
2017
46
Long-interval Cytapheresis as a Novel Therapeutic Strategy Leading to Dosage Reduction and Discontinuation of Steroids in Steroid-dependent Ulcerative Colitis. ( 28924114 )
2017
47
Colonic Histological Criteria Predict Development of Pouchitis after Ileal Pouch: Anal Anastomosis for Patients with Ulcerative Colitis. ( 28662525 )
2017
48
Over 90% of cases of Microscopic Colitis can be diagnosed by performing a short colonoscopy. ( 28215538 )
2017
49
Fecal Calprotectin Rise in Chronic Granulomatous Disease-Associated Colitis. ( 28879453 )
2017
50
Extract from mango mistletoes Dendrophthoe pentandra ameliorates TNBS-induced colitis by regulating CD4+ T cells in mesenteric lymph nodes. ( 28946886 )
2017

Variations for Colitis

Expression for Colitis

Search GEO for disease gene expression data for Colitis.

Pathways for Colitis

Pathways related to Colitis according to GeneCards Suite gene sharing:

(show top 50) (show all 72)
id Super pathways Score Top Affiliating Genes
1
Show member pathways